NHS Implant Analysis Service - nthsolutions.co.uk

A fast, cost effective, NHS led service operated by NTH Solutions, providing independent analysis of explanted medical devices.

To date there has not been an easily accessible and affordable explant analysis service within the NHS, and so most explanted revised joints end up in the operating room bin.

With the introduction of the NHS Implant Analysis Service, hospitals and surgeons now have access to a fast, cost effective, NHS led service.

The launch of this service enables the cost-effective analysis of explanted devices and provision of expert reports to surgeons and multi-disciplinary teams (MDTs), providing additional data to support patient reviews and insights that can inform clinical practice.

Download our brochure

Visit Website

Benefits:

Early detection of characteristic failure patterns

Explant analysis enables the early detection of characteristic failure patterns, ensuring that devices which may be performing sub-optimally are rapidly identified

Identify prostheses with atypical features

Corrosion and wear of explants can be quantified and mapped, so that prostheses exhibiting atypical features can be identified

Rapid and accurate analysis

Prosthetic surfaces can be analysed rapidly and accurately to identify issues which may not be visible to the naked eye

Adverse reactions detection (ARMD)

Adverse reactions to metal debris (ARMD) can often mimic infection in their clinical presentation. Analysis of explanted components may identify abnormal wear or corrosive processes commonly associated with ARMD

MHRA Link

‘The Medicines Healthcare products Regulatory Agency (MHRA) is actively involved in discussions and supports the development of implant explant centres. Benefits of implant explant centres include the potential for earlier detection of safety signals relating to medical devices which contributes to improving patient safety. We are keen to ensure that all adverse events identified are reported to the MHRA via the Yellow Card scheme for England and Wales or through national reporting authorities in Scotland and Northern Ireland. Manufacturers hold responsibilities to monitor the safety and performance of their devices. The information in the generated reports can hold rich information to support this. The MHRA would support manufacturers having access to this information and the device post explant for further investigation

“In BC (Beyond Compliance) we have always thought that explant analysis of all retrieved implants, particularly if they are novel, should be undertaken. To date this has hardly happened and BC and ODEP are delighted that the NHS Implant Analysis Service is going to facilitate this essential part of implant monitoring.”

Keith Tucker,

Chair of ODEP and the Beyond Compliance Advisory Group. Autumn 2022

Visit the NHS Implant Analysis Service website here: